3D Global Biotech Inc. (TPEX:6808)
Taiwan
· Delayed Price · Currency is TWD 61.30
+0.10 (0.16%)
Apr 2, 2025, 2:56 PM CST
3D Global Biotech Market Cap
3D Global Biotech has a market cap or net worth of 4.77 billion as of April 2, 2025. Its market cap has increased by 122.38% in one year.
Market Cap
4.77B
Enterprise Value
4.44B
Revenue
55.15M
Ranking
n/a
PE Ratio
n/a
Stock Price
61.30
Market Cap Chart
Since December 25, 2020, 3D Global Biotech's market cap has increased from 2.74B to 4.77B, an increase of 74.38%. That is a compound annual growth rate of 13.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2025 | 4.76B | -7.15% |
| Dec 31, 2024 | 5.13B | 371.49% |
| Dec 29, 2023 | 1.09B | -27.35% |
| Dec 30, 2022 | 1.50B | -30.09% |
| Dec 30, 2021 | 2.14B | -18.98% |
| Dec 31, 2020 | 2.64B | -3.35% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 178.51B |
| Caliway Biopharmaceuticals | 120.14B |
| Bora Pharmaceuticals Co., LTD. | 71.17B |
| Lotus Pharmaceutical | 61.56B |
| Oneness Biotech | 33.46B |
| Lumosa Therapeutics | 29.98B |
| Pegavision | 28.08B |
| Center Laboratories | 27.41B |